Teladoc Health Inc [TDOC] stock is trading at $8.93, up 8.24%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TDOC shares have gain 6.69% over the last week, with a monthly amount glided 16.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on July 25, 2025, when Mizuho initiated its Neutral rating and assigned the stock a price target of $10. Previously, Goldman started tracking the stock with Buy rating on November 15, 2024, and set its price target to $14. On September 17, 2024, Jefferies reiterated its Hold rating and revised its price target to $10 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $22 on February 29, 2024. Leerink Partners initiated its recommendation with a Market Perform and recommended $17 as its price target on February 26, 2024. DA Davidson downgraded its rating to Neutral for this stock on January 17, 2024, and downed its price target to $22. In a note dated January 03, 2024, Barclays initiated an Overweight rating and provided a target price of $26 on this stock.
Teladoc Health Inc [TDOC] stock has fluctuated between $6.35 and $15.21 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $8.93 at the most recent close of the market. An investor can expect a potential return of 11.98% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Teladoc Health Inc [NYSE:TDOC] reported sales of 2.54B for the trailing twelve months, which represents a drop of -1.64%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.14 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Teladoc Health Inc’s Current Ratio is 2.59. As well, the Quick Ratio is 2.49, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 0.62, the price to book ratio is 1.11.
Transactions by insiders
Recent insider trading involved Catapano Joseph Ronald, Chief Accounting Officer, that happened on Oct 02 ’25 when 2972.0 shares were sold. CHIEF EXECUTIVE OFFICER, DIVITA CHARLES III completed a deal on Sep 11 ’25 to sell 16787.0 shares. Meanwhile, Officer DIVITA CHARLES III bought 16787.0 shares on Sep 11 ’25.
